NCT02216838View on ClinicalTrials.gov

Treatment of Facial Flushing With Botulinum Toxin A Injections

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Facial Flushing
Interventions
DRUG

botulinum toxin A

A total of 10U will be injected at 1cm increments by the blinded dermatologist into the respective randomized side.

OTHER

Saline Control

A total of 0.5cc benzyl alcohol containing saline will be injected at 1cm increments by the blinded dermatologist into the respective randomized side

Trial Locations (1)

60611

Northwestern University Feinberg School of Medicine, Department of Dermatology, Chicago

All Listed Sponsors
lead

Northwestern University

OTHER